ARTICLE | Company News
Exelixis, Scios deal
October 15, 2001 7:00 AM UTC
The companies will develop a high throughput screening library of small molecules for inflammatory and cardiovascular diseases. EXEL will use its combinatorial chemistry platform to generate the libra...